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Abstract. Post-transcriptional control of mRNA trafficking 
and metabolism plays a critical role in the actualization and 
fine tuning of the genetic program of cells, both in devel-
opment and in differentiated tissues. Cis-acting signals, 
responsible for post-transcriptional regulation, reside in the 
RNA message itself, usually in untranslated regions, 5' or 3' 
to the coding sequence, and are recognized by trans-acting 
factors: RNA-binding proteins (RBPs) and/or non-coding 
RNAs (ncRNAs). ncRNAs bind short mRNA sequences 
usually present in the 3'-untranslated (3'-UTR) region of their 
target messages. RBPs recognize specific nucleotide sequences 
and/or secondary/tertiary structures. Most RBPs assemble on 
mRNA at the moment of transcription and shepherd it to its 
destination, somehow determining its final fate. Regulation 
of mRNA localization and metabolism has a particularly 
important role in the nervous system where local translation of 
pre-localized mRNAs has been implicated in developing axon 
and dendrite pathfinding, and in synapse formation. Moreover, 
activity-dependent mRNA trafficking and local translation 
may underlie long-lasting changes in synaptic efficacy, respon-
sible for learning and memory. This review focuses on the role 
of RBPs in neuronal development and plasticity, as well as 
possible connections between ncRNAs and RBPs.
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1. Introduction
Post-transcriptional regulation is fundamental for determining 
the appropriate time and place at which a given mRNA is 
translated and its half-life. Processes as different as cell fate 
determination during embryogenesis, differentiated cell 
response to physiologic or stress cues, and stabilization of 
memories depend on pre-localization and the regulated trans-
lation of specific sets of mRNAs. RNA is thus the carrier of 
the two messages that are to be translated into the protein and 
of the detailed information concerning where and whether 
it is to be translated (1). Moreover, while mRNAs encoding 
housekeeping proteins, such as cytoskeletal components, have 
on average short decay rates of days, mRNAs encoding regula-
tory proteins, such as transcription factors, have half-lives of 
minutes (2). Deregulation of both short-lived mRNA stability 
and/or localization/translation may cause marked alterations 
in cell function, ranging from cancer to cell death.
Post-transcriptional regulation largely depends on the 
activity of a number of general and specific RNA binding 
proteins (RBPs) that recognize consensus sequences and/or 
structural features, mainly located in the 3'-untranslated region 
(3'-UTR) of mRNAs but that can also be present in the 
5'-untranslated- (5'-UTR) and coding sequences. Several 
RBPs bind primary transcripts (heterogeneous nuclear RNAs: 
hnRNAs) following transcription (Fig. 1), leading to the 
assembly of nascent heterogeneous nuclear ribonucleoprotein 
complexes (hnRNPs). In the context of hnRNPs, hnRNA 
undergoes 3'-end cleavage and the addition of a poly(A) tail, 
and these events promote transcription termination and the 
assembly of a dynamic enzymatic complex, the spliceosome. 
The spliceosome, which contains five small nuclear RNPs 
(snRNPs) and numerous proteins, is responsible for intron 
selection and removal, and the appropriate joining of exons (3). 
RNA protein interactions in the spliceosome are crucial for 
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determining which sequences should be retained in the mature 
message, and function as checkpoints before mRNA transport 
to the cytoplasm. Conformational perturbations within the spli-
ceosome can control alternative splicing decisions (4). Notably, 
the molecular interactions within the spliceosome may be even 
more complex during maturation of pre-mRNAs containing 
very large introns, for which nested splicing events have been 
recently suggested (5), as well as of mRNAs containing ultra-
short introns (6). The fact that crucial decisions are taken 
during maturation of the primary transcript suggests that the 
nuclear history of mRNA can be determined for its stability 
and translation into the cytoplasm (7). The nucleo-cytoplasmic 
traffic of RNPs occurs through the nuclear pore complex 
(NPC), and requires nuclear export signals (NES), present on 
RBPs. The directionality of nucleo-cytoplasmic traffic depends 
on remodelling of the mRNPs on the cytoplasmic side of the 
nuclear envelope (8). Several RBPs also contain nuclear local-
ization signals (NLS), and shuttle between the nucleus and the 
cytoplasm. Modulation, by post-translational modifications, of 
RBP ability to enter the nucleus and/or to exit from it may be 
one of the earliest regulatory steps in the pathway leading to the 
translation of a given mRNA.
Once in the cytoplasm, mRNPs are capable of binding 
to motor proteins, which mediate their transport, in a trans-
lationally inactive form, along the cytoskeletal filaments. At 
their final destinations, mRNAs are immediately translated or 
stored until a signal-dependent remodelling of mRNPs occurs. 
Molecular mechanisms allowing the selective translation of 
pre-localized mRNAs are of the most importance in both the 
developing and adult nervous system, and can be at the basis 
of learning and memory processes.
2. Regulatory signals and regulatory factors
General. Post-transcriptional regulation depends on the 
sequences/structures present on mRNA (cis-acting elements), 
and trans-acting factors, and the ability to recognize them. 
In addition, RNA protein interactions can be modulated over 
time by extracellular signal transduction pathways that target 
RBPs, inducing their post-translational remodelling.
Cis-acting determinants present on mRNA. RNA is a highly 
dynamic molecule able to fold into complex secondary 
and tertiary structures, based on standard C:G/A:U base 
pairs as well as on non-Watson-Crick interactions (9-14) 
generating different conformers with different biological 
activities. During folding, RNA has the tendency to be trapped 
in inactive tridimensional structures (15) and it is not easy to 
envisage thermodynamically predominant isoforms of a given 
mRNA (16,17). Two main classes of RNA-binding proteins 
cooperate in vivo with RNA in the acquisition of functional 
structures: i) RNA chaperones, such as RNA helicases of the 
DEAD-box family, or unwindases (18-20), which prevent 
and/or resolve misfolded structures (15,21-23), and ii) tertiary 
structure-binding proteins, which are able to recognize and 
stabilize the ‘correctly’ folded RNAs (induced fit) (16).
In general terms, cis-acting determinants or ‘zipcodes’ 
can be formed by simple sequences and/or secondary/tertiary 
structure elements (24,25). Fig. 2a is a schematic drawing of 
mRNA structural organization. Zipcodes may occasionally 
function independently of the precise sequence context in 
which they are normally found: they are capable of driving 
the localization of any reporter message to which they are 
fused. However, not all the zipcodes are position-independent. 
Some RNAs contain multimers of a single motif, while others 
contain multiple cis-acting determinants; in both cases, 
multiple zipcodes mediate multiple steps in the localization 
process by acting synergistically (25).
Trans-acting factors: RNA-binding proteins (RBPs) and 
non-coding RNAs (ncRNAs). Cis-acting determinants are 
recognized by RBPs that assemble on RNA, forming RNA 
protein particles (RNPs) of different and regulated composi-
tion. In most cases, trans-acting factors recognize a specific 
secondary structure in the RNA, often a hairpin stem-loop 
structure, along with a small number of specific anchoring 
nucleotides (25). RNA recognition and binding is mediated 
by different families of RNA-binding domains, a summary of 
which is shown in Fig. 2b.
Most RBPs contain more than one RNA-binding domain, 
which has been shown to act synergistically by intra-molec-
ular- (26,27) or inter-molecular-cooperativity (28). Conversely, 
the same RBP is able to recognize different sequence elements 
within the target mRNA, and recognition can require the 
correct spatial positioning of these sequences (29). More 
importantly, binding of all elements can affect overall affinity 
of the RBP for the target mRNA. This cooperative effect 
depends on significant unfolding or the structural changes the 
mRNA undergoes after the first contact with the RBP (26,30). 
This observation is important when we consider that mRNA 
also interacts with non-coding RNAs, the regulatory role of 
which has been recently recognized (see below).
A widely diffused RNA-binding domain is the ribonucleo-
protein (RNP) motif or RNA recognition motif (RRM). RRMs 
contain ~90 amino acids and one or more copies of it were 
initially identified in proteins that bind heterogeneous nuclear 
(hn) pre-mRNA (hnRNP) (12,31). Proteins present in hnRNPs 
also contain a variable number of Arg-Gly-Gly (RGG) repeats 
that in most cases seem to be non-specific binding domains, 
acting in cooperation with other RNA-binding domains (31). In 
alternative or in addition to RRM and RGG motifs, hnRNPs may 
contain one or more domains known as K-homology (KH) after 
hnRNP K, the first protein in which the motif was identified (32).
Several RBPs contain an RNA-binding domain with a 
preference for double-stranded stretches of RNA (dsRNA-
binding motif: DSRM). The prototypic DSRM was found 
in Staufen (Stau), a protein required for maternal mRNA 
localization in Drosophila egg (33). Stau is also involved in 
the regulation of mRNAs required for memory formation 
in both Drosophila and Aplysia (34,35). In mammals, two 
Stau isoforms are present, which bind to distinct, although 
overlapping, sets of mRNAs (36). Recently, Stau has been 
reported to regulate pyramidal cell spine morphology via 
NMDA receptor-mediated synaptic plasticity (37). Moreover, 
it probably forms a functional complex with the fragile X 
mental retardation protein (FMRP) and the 43 kDa transactive 
response DNA-binding protein (TDP-43), both of which are 
related to nervous system pathologies (see below) (38).
The most abundant protein family in the mammalian 
genome is probably constituted by zinc-finger-containing 
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proteins (39), which contain several types of Cys-Cys (CC) 
or Cys-His (CH) motifs, and were considered primarily as 
transcriptional regulators. The first identified zinc-finger 
containing protein, TFIIIA, is necessary for the transcription, 
by RNA polymerase III, of the genes encoding ribosomal 5S 
RNA, but is also able to bind ribosomal 5S RNA itself in the 
7S ribonucleoparticles stored in the cytoplasm of amphibian 
oocytes. Similarly, many other members of the family are able 
to bind the two classes of nucleic acids or RNA only (40,41).
In mammals, one example of CCHH zinc finger domain-
containing RBP is hZFP100, involved in the processing of 
histone mRNAs (42), while a CCCH domain characterizes 
tristetraprolin (TTP), which participates in mRNA decay (43). 
TTP and the other members of the TIS11 family have a 
crucial role in post-transcriptional regulation, targeting for 
degradation ARE-containing mRNAs (44,45). In rat brain, 
an interaction between PABP (poly-A binding protein) and 
Makorin 1 (MKRN 1), a RING zinc finger protein, has been 
recently demonstrated (46). By binding to PABP and dendritic 
mRNAs, MKRN1 was able to regulate translation at synapses 
in response to stimuli inducing synaptic plasticity (46).
Another domain, found in RBPs as well as in DNA-binding 
proteins, is the cold-shock domain (CSD), first identified 
in bacterial RNA chaperones and then found in a number 
of eukaryotic proteins (Y-box proteins), which is able to 
interact with single-stranded DNA and/or RNA (47). In one 
of the best studied CSD-containing proteins, the Xenopus 
protein FRGY2, the CSD was shown to be important for the 
sequence-specific RNA-binding, while a second tail domain 
was involved in translation repression (48). Y-box protein 
(YB)-1, the prototypic member of the CSD-containing protein 
family, is both a transcription factor and a major component 
of mRNPs. We recently demonstrated that in nuclear extracts 
from rat brain, YB-1 interacts with a group of proteins that 
bind the mRNA encoding the histone variant H1 .˚ Among 
these proteins another CSD-containing protein, CSD-C2, also 
known as PIPPin (49), was present (50).
Proteins that do not contain any conventional RNA-binding 
domains have been shown to bind RNA. The variety of 
trans-acting domains should therefore be larger than expected. 
Examples of proteins, already known for other well-estab-
lished functions, which are also able to bind RNA, include 
thymidylate synthase (51), mitochondrial glutamate dehydro-
genase (52), cytosolic glyceraldehyde-3-p dehydrogenase (53), 
and the calmodulin-binding protein PEP-19 (also known as 
PCP-4 in humans) (54).
Besides RNA-binding proteins, regulation of the mRNA 
metabolism also involves non-coding RNAs (ncRNAs). A high 
proportion of complex genomes gives rise to ncRNAs, among 
which the most widely studied class is that of miRNAs, small 
RNAs of ~22 nucleotides (nt) that recognize specific sequences 
present in the 3'-UTR of target mRNAs. By binding their target 
mRNAs, miRNAs mediate post-transcriptional gene silencing, 
through an increase of mRNA decay rate and/or inhibition 
of translation (55-58). Deregulation of miRNA functions is 
involved in cancer development (59-61) and in a number of 
other human diseases, including neurological syndromes (62).
Biogenesis of miRNA is a multi-step process that starts 
in the nucleus with the transcription of a long precursor 
(pri-miRNA). Following the sequential action of the 
RNase III enzymes Drosha and DICER, a dsRNA of ~22 nt 
is produced in the cytoplasm, resulting in the formation of the 
RNA-induced silencing complex (RISC) in which only one 
strand of the dsRNA is inserted that contains members of the 
Argonaute (Ago) protein subfamily as catalytic endonuclease 
components (56).
An increasing number of functional interactions have 
been identified between RBPs and miRNAs. In general 
Figure 1. Post-transcriptional fate of mRNA. During transcription (step 1) by RNA Polymerase II (Pol II), the nascent heterogeneous nuclear primary transcript 
(nascent hnRNA) is complexed with RNA-binding proteins (RBPs) (hnRBPs), some of which are also involved in splicing (step 2), together with small nuclear 
ribonucleoparticles (snRNPs). In the splicing process, introns are removed and exons are joined together, to obtain a mature mRNA, complexed with RBPs 
[mature RNA-protein particles (RNP)], ready to be transported to the cytoplasm (step 3), through interaction with proteins of the nuclear pore complex. In the 
cytoplasm, RNPs attach to cytoplasmic motor proteins, which mediate the microtubule-dependent transport of mRNA to its final destination.
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terms, RBPs and miRNAs may cooperate or counteract in the 
regulation of a given mRNA. Examples of the two types of 
RBPs-miRNA interplay have been identified in different types 
of cancer cells (63). The role of miRNAs in neurons has also 
been identified and previously assessed (64,65,66). Since a 
number of RBPs are uniquely, or almost uniquely, expressed in 
the nervous system, the possibility exists that they are capable 
of regulating the interaction among mRNAs and certain 
groups of miRNAs in a specific way, in turn regulating the 
establishment and/or maintenance of the unusual functions of 
this tissue.
Signaling pathways that control mRNA localization and 
metabolism. All the steps of RNA metabolism, from splicing 
and maturation in the nucleus to final degradation, are affected 
by the cellular microenvironment and by extracellular signals, 
such as hormones, growth factors, physical and chemical stress 
stimuli, as well as neurotransmitters (Fig. 3). All these cues are 
known to affect mRNA stability and translation by triggering 
signaling pathways that cause post-translational modifications 
of specific RBPs. A variety of post-translational modifications 
affecting RBPs have been identified, including serine/threo-
nine phosphorylation, proline hydroxylation, arginine/lysine 
methylation, lysine ubiquitination or SUMOylation and lipida-
tion. These chemical modifications influence affinity and/or 
specificity of protein-protein and/or RNA-protein interactions, 
and are consequently critical for the rapid remodelling of ribo-
nucleoprotein complexes and for the stability and localization 
of mRNAs (2,67).
Localized mRNAs are transported close to the plasma 
membrane or organelles, suggesting that membrane-bound 
kinases play an important role in the regulation of the 
translation of localized transcripts, in response to extracel-
lular signals (68). Extracellular cues also activate retrograde 
pathways that may even reach the nucleus, inducing the modi-
fication of chromatin organization of genes and, in turn, gene 
Figure 2. Structural organization of mRNA and best known RNA-binding domains. Schematic representation of (a) mRNA molecule, showing both the open 
reading frame (ORF, from an AUG codon to a UGA codon) encoding for a protein, and the untranslated regions (UTR) 3'- and 5'- to the coding sequence. The 
cap structure at the 5'-end, and the poly(A) tail at the 3'-end are also indicated. As described in the text, RNA-binding proteins (RBPs) recognize and bind either 
secondary/tertiary structures (stem loops in the figure), or simple sequence elements (SSE). The most common RNA-binding domains are summarized in b.
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expression. In this manner, responses to extracellular signals 
and neural activity may also be converted into a stable modifi-
cation of the cell phenotype.
At least three major mechanisms are known for dynamic 
modification of chromatin organization: i) chromatin remodel-
ling by ATP-dependent complexes (69); ii) post-translational 
modification of histone proteins (70), and iii) replacement of 
histone isotypes present in chromatin with other isotypes (71). 
During rat brain development, at least histones H3.3, a core 
histone variant, and H1 ,˚ a linker histone variant, have been 
shown to accumulate during the terminal differentiation of 
nerve cells (72,73), in the absence of gene activity changes. 
Post-transcriptional regulation of the expression of these 
two histones probably depends on the activity of a group 
of RNA-binding proteins (74,49), some of which have been 
identified and cloned (75,76). Among these proteins, one was 
already known as Purkinje cell-expressed peptide (PEP-19, or 
PCP-4 in humans), but is also expressed in a neuron-specific 
manner in other brain regions (77,78).
PEP-19 is a calmodulin-binding protein that is known to 
bind H1˚ mRNA (54). Similarly, PIPPin (also known as CSDC2) 
binds H3.3 and H1˚ mRNAs (49); it is a phosphoprotein that 
can be phosphorylated by different kinases (79, unpublished 
data), and that interacts with other proteins already known 
to bind RNA (50). It may therefore be hypothesized that, in 
response to calcium-dependent neuronal activity, proteins of 
this type are modified. Their post-translational modification 
may in turn change their interaction with histone variant 
mRNAs, thus inducing their translation and accumulation 
of the corresponding proteins. Histone variants could finally 
enter chromatin, thus modifying the structural organization 
and expression of specific genes.
3. Messenger RNA trafficking and localization in neurons
Mature transcripts can be localized through at least three 
mechanisms: i) local protection from degradation, ii) diffusion 
and local anchoring, and iii) direct transport by inter action 
with the cytoskeleton and cytoskeleton-associated motor 
proteins (80-82). Subcellular pre-localization of mRNAs 
and locally regulated translation offer cells at least three 
important advantages: i) energy saving: a high number of 
protein molecules can be obtained locally by transporting 
and translating a single mRNA molecule; ii) efficacy/safety 
of protein production: some proteins may be harmful to the 
cells when synthesized in the incorrect location; the myelin 
basic protein (MBP), a major component of the axon-wrapping 
myelin sheet, produced in the central nervous system (CNS) by 
oligodendrocytes, is, for example, a sticky protein that poten-
tially interacts with any cell membrane if produced in the cell 
body (12,83,84); other proteins, such as actin, tubulin and 
microtubule-associated proteins, exist as different isoforms, 
all able to form multimers/polymers; their localized synthesis 
allows the formation of only the right multimers; iii) differ-
ential translation regulation: in response to local signaling, 
proteins may be synthesized only in the compartment exposed 
to the signal (85,86).
Pre-localization of mRNA is determined in polarized 
cells (87). The most asymmetric cells in the body are neurons, 
which consist of a cell body or soma, several branched dendrites 
Figure 3. RNA traffic in neurons. As shown in Fig. 1, at the time of transcription, nascent RNA was already complexed with RNA-binding proteins (RBPs) to 
form RNA-protein particles (RNPs), which then migrate to the cytoplasm through the nuclear pore complex. In the cytoplasm, through interaction with motor 
proteins, RNPs are transported to their final destinations, where they can pause in a silent state, until they are activated by a signal. Some components of RNPs 
can then be cycled back to the nucleus. When exiting the nucleus, however, two different peripheral destinations are available to RNPs: a) dendrites or b) axon. 
Localized translation of mRNA may be controlled by synaptic activity (action potential). In response to neurotransmitters and/or neuromodulators, which bind 
to their receptors on the post-synaptic element, signal transduction pathways can be activated (red dotted lines), which target RBPs, inducing post-translational 
modifications, such as phosphorylation. RBP modifications in turn cause remodelling of the RNPs, with the release of some RBPs and recruitment of mRNA 
to ribosomes. Newly synthesized proteins accumulate at the post-synaptic sites, thus inducing long-lasting modifications. SVs, neurotransmitter-containing 
synaptic vesicles. Synthesis, maturation, and transport of RNPs are shown as in Fig. 1.
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and a long axon that can be 1,000-fold the diameter of the 
cell body (88). The most noteworthy property of nerve cells 
is the variety of morphologically different sub-compartments. 
Therefore, how a neuron, with only one cell nucleus and thus 
a single supply of active genes, obtains such a motley distribu-
tion of proteins if of interest and should be investigated.
mRNA pre-localization in dendrites. Through utilization of 
different experimental approaches, such as in situ hybrid-
ization, and amplification of mRNAs present in neuronal 
processes, the presence in dendrites of a large number of 
mRNAs was clearly demonstrated. Among the dendriti-
cally localized messages the most intensively studied are 
those encoding microtubule-associated protein 2 (MAP2), 
the brain-derived neurotrophic factor, the α subunit of the 
calcium/calmodulin-dependent protein kinase II (CaMKIIα), 
the activity-regulated cytoskeleton-associated protein (Arc), 
the NMDAR NR1 subunit, and the AMPA receptor (84,89,90). 
Dendritic RNA transport is specific and can be regulated by 
neuronal activity in a rapid manner (91,92).
Information required for the successful mRNA transport 
to dendrites is sometimes contained in a single zipcode, as in 
the case of the non-protein coding, dendritically localized BC1 
mRNA, which contains, at its 5'-end, a 62 nt zipcode, able to 
fold into a single stem-loop and to drive microtubule-depen-
dent transport (25,93-95). Other mRNAs have more complex 
localization signals. The MAP2 mRNA, for example, contains 
a 640 nt zipcode element in its 3'-UTR, probably created with 
distinct sub-elements that fold into multiple stem-loops (96), 
and are able to mediate individual steps of RNP assembly 
and localization process. Similarly, the mRNA encoding the 
myelin basic protein in oligodendrocytes contains two distinct 
elements: i) A2RE, an 11 nt element found only in transcripts 
that are localized (97); it forms the binding site for hnRNP A2 
and is necessary and sufficient for transport (98,99), and ii) a 
1 kb long element, essential for appropriate localization of a 
protein-coding reporter RNA, and probably involved in RNA 
anchoring (25). Of note, the A2RE element was also identi-
fied in the neuronal mRNAs encoding CaMKIIα, Arc and 
neurogranin, all of which were assembled in the same gran-
ules containing hnRNP A2, and targeted to dendrites (100). 
Conversely, it has also been reported that the dendritically 
localized mRNAs encoding MAP2, CaMKIIα, and β-actin 
assemble in distinct RNPs, which contain very few RNA 
molecules (101,102).
Besides positively acting elements, elements that inhibit 
transport also exist. Localization of CaMKIIα depends on 
the 3'-UTR (103), which contains three positive cis-acting 
regions: i) a stretch of ~1200 nt, in the latter half of the 3'-UTR, 
sufficient for localization (104); ii) one element present in the 
distal 170 nt of the UTR, which contains cytoplasmic poly-
adenylation elements (CPEs) (105), and requires a wild-type 
CPE-binding protein (CPEB); iii) a third zipcode, within 
the first 94 nt of the 3'-UTR, which contains the already 
mentioned, 30-nt long sequence with high homology to an 
element present in neurogranin mRNA. Other elements in the 
CaMKIIα mRNA, on the contrary, inhibit its transport, in the 
resting state, while inhibition is eliminated in the depolarized 
neurons as activity-dependent derepression is critical for their 
dendritic targeting (106).
Taken together, these findings suggest that assembly and 
transport of mRNAs involves different signals and highly 
specific RNA scanning by regulatory proteins. This complexity 
is likely at the origin of the several types of RNPs that have 
been described, such as transport RNPs, stress granules 
(SGs), processing bodies (P-bodies), and P-body-like struc-
tures (107-112). Composition of the complexes may vary with 
growth conditions, and different mRNA subsets are potentially 
present in different classes of particles; conversely, the same 
mRNA species may be found in multiple mRNP complexes. 
Based on these observations, Keene and Tenenbaum suggested 
that RBPs may regulate mRNAs as subpopulations during 
cell growth and development. Their model predicted that 
functionally related genes were regulated as groups or post-
transcriptional operons, by specific mRNA-binding proteins 
that recognize sequence elements common among the 
mRNAs (113). One of these ‘master’ RBPs that controls the 
expression of several mRNAs at a time is the Fragile X mental 
retardation protein (FMRP), which regulates dendritic mRNA 
transport and local protein synthesis on the post-synaptic side 
of synapses. Over 400 mRNAs have been reported to asso-
ciate with FMRP. FMRP interacts with kinesins and is able 
to repress translation of its client mRNAs both in vitro and 
in vivo. More recently, FMRP has also been found in axons 
and growth cones, where it seems to be involved in responses 
induced by Semaphorin-3A (Sema3A) (114).
The specific interaction between RNAs and RBPs suggests 
the existence of an ‘RNA signature’ that characterizes each 
transcript (84,100). For example, the BC1 RNA assembles with 
proteins to form an RNP involved in the transport of dendritic 
mRNAs (93); the signal responsible for its dendritic targeting is 
a motif at its 5'-end, which folds into a single stem-loop instead 
of into a cloverleaf structure, as expected on the basis of its 
sequence similarity to tRNA. Notably, tRNAs also migrate to 
dendrites, but some of them remain and function in the cell 
body. It has been suggested that its structural properties allow 
BC1 RNA to be transported to dendrites more efficiently than 
tRNAs (94).
Further sources of cis-acting signal variability are alter-
native splicing and alternative polyadenylation site selection. 
These processes are capable of generating different RNA 
isoforms with different targeting specificities. In brain neurons, 
two distinct pools of brain-derived neurotrophic factor (BDNF) 
transcripts are produced by the differential use of polyadenyl-
ation sites, i.e., mRNA molecules with the longer 3'-UTR, but 
not those with the shorter one, contain localization elements, 
which target them to dendrites (115). At the same time, the 
longer 3'-UTR also mediates BDNF translation repression in 
the resting state and activity-dependent translation (116). In a 
recent study, it has been found that the longer 3'-UTR contains 
an AU-rich element (ARE) that interacts with the neuronal 
RBP HuD. Such an interaction is necessary and sufficient for 
the stabilization of the longer mRNA isoform (117).
A shorter and longer 3'-UTR species also exists in the 
case of CaMKIIα mRNA, although the long mRNA is much 
more abundant. Again, the sequence required for dendritic 
targeting has been mapped downstream to the first poly-
adenylation site (104), suggesting that the shorter mRNA 
isoform is confined to the cell body, while the longer mRNA 
is transported to dendrites. It therefore seems that the strategy 
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of alternative 3'-UTRs may be commonly adopted by genes 
encoding proteins with important functions in the cell body 
and dendrites.
As mentioned, cis-acting elements interact with RBPs that, 
by recognizing and binding them, control mRNA localization 
and stability and thus play an important role in the develop-
ment and maintenance of the nervous system. Moreover, 
coordinated expression of neural genes may be obtained by 
assembly of their mRNAs in common mRNP complexes, 
which can contain different RBPs under different cell states 
and at different times (118). This process is of particular 
importance in modulating synaptic plasticity which seems 
to depend on the activity-induced translation of hundreds of 
locally targeted mRNAs, present in neuronal processes, where 
they drive a variety of specific functions (119).
For instance, mammalian zipcode-binding protein 1 (ZBP1) 
is required for the dendritic targeting of β-actin mRNA both 
in developing and mature neurons (120-122). Knockdown of 
ZBP1 in cultured hippocampal neurons reduced the dendritic 
levels of ZBP1 and β-actin mRNA and impaired the growth of 
dendritic filopodia in response to BDNF treatment (120). This 
observation is important when considering that the formation 
and density of dendritic filopodia during neuronal development 
are likely to be connected to the process of synaptogen-
esis (120,123-125). Phosphorylation of ZBP1, in response to 
extracellular signals such as BDNF, by the membrane-bound 
Src tyrosine kinase results in a decreased affinity of ZBP1 for 
its bound mRNA and consequent local activation of mRNA 
translation (126-128). However, only ~50% of β-actin mRNA 
colocalizes with ZBP1 (92), thus suggesting the involvement 
of other RBPs in the localization/translation regulation of this 
mRNA. Another RBP required is the Src-associated with a 
mitosis of 68 kDa (Sam68): knocking down Sam68 in neuronal 
cultures or interfering with its binding to β-actin mRNA 
causes a deficit of β-actin mRNA in dendrites and in spine 
density (122), while loss of Sam68 has been connected with 
the pathogenesis of neurodegenerative fragile X tremor/ataxia 
syndrome (FXTAS) (129,130).
T h e  z ip c o d e - b i n d i ng  p r o t e i n ,  Z BP 2 ,  wa s 
identified in chicken embryo brain by RNA affinity chroma-
tography (through binding to an RNA fragment containing the 
zipcode) (131). ZBP2 is a predominantly nuclear protein that 
also affects β-actin mRNA localization in the cytoplasm; it is 
the chicken homologue of the human KH domain-containing 
splicing regulatory protein (KSRP), a protein involved in pre-
mRNA splicing (132). The homologue of ZBP2 in rat is the 
MAP2-RNA trans-acting protein (MARTA1), which binds the 
3'-UTR of MAP2 mRNA, a dendritically localized neuronal 
transcript (133,134). ZBP2 has been found to bind the nascent 
β-actin zipcode co-transcriptionally and to facilitate binding 
of ZBP1 to the zipcode (135). It provides an example of how 
interactions between RNA-binding proteins and RNA serve to 
recruit and stabilize additional proteins to form a large RNP.
Another well-studied factor involved in mRNA localiza-
tion and, probably, modulation of translation is the already 
mentioned HnRNP A2 which binds MBP mRNA, allowing 
its correct localization in the oligodendrocyte processes in 
which myelination occurs (127). hnRNP F has been found to 
be a component of MBP transport granules, and to cooperate 
with HnRNP A2 in regulating MBP expression. Activity of 
this factor is controlled through phosphorylation by the Fyn 
kinase (136). HnRNP A2 was found in dendrites, in associa-
tion with other hnRNPs, in large macromolecular complexes 
(neuronal transport granules) that contain mRNA, pre-mRNA 
splicing factors, and mRNA export factors (137). The presence 
of proteins with different roles in RBP granules is a common 
observation: for example, the complex responsible for dendritic 
targeting of a CaMKII reporter contains PSF (polypyrimidine 
tract-binding protein-associated splicing factor), hnRNPU and 
Staufen 1 RNA-binding proteins (127).
mRNA pre-localization in axons. When discussing mRNA 
localization determinants in neurons, a challenging issue 
comes from the finding that mRNAs can be also localized 
in axons. For a long time, this possibility was not considered 
since the translational machinery did not seem to be present 
at significant levels in axons. Moreover, mechanisms ensuring 
protein transport from cell bodies to the axonal compartment 
were, on the contrary, present and efficient, thus making 
apparently unnecessary localized protein synthesis. However, 
findings of previous studies have demonstrated axonal local-
ization and translation of several mRNA (138-144), including 
the β-actin mRNA (145-147), which depends on the zipcode 
recognized by ZBP1 for localization (148).
Together with β-actin transcript, mRNAs for which axonal 
localization has been reported include those for oxytocin and 
vasopressin (149,150), β-tubulin (151), actin-depolymerizing 
factor ADF/cofilin (152), the microtubule-associated 
proteins 1b (MAP1b) (153) and τ (154), the cytoskeleton 
regulating protein RhoA (155), the κ opioid receptor (156) 
and heat shock proteins (157). Notably, among axonally 
localized mRNAs, transcripts encoding transcription factors 
have been found, an example being CREB mRNA (158). 
Moreover, after injury, the population of localized mRNA 
enlarges to include many transcripts encoding proteins of the 
translational apparatus and trans-membrane receptors (159). 
Thus, as with dendrites, a supply of mRNAs exists in axons, 
and some of these transcripts can be translated under special 
circumstances (160). In addition, the pool of axonal mRNAs 
markedly changes during development: in embryonic axons 
exclusively transcripts belonging to the ‘cellular assembly 
and organization category’ were found. These transcripts can 
be further subdivided into smaller subsets of cytoskeletal-
related mRNAs and transport of vesicles/trafficking-related 
mRNAs (161). These observations suggest that, at least in the 
growing axons, localized protein synthesis may allow dynamic 
remodelling of the axons during their progression through the 
extracellular environment.
Localization and translation of mRNA in axons still pose 
two main problems. The first one concerns the organization 
and regulation of the translational machinery: axoplasm 
structural domains have been recently described (periaxo-
plasmic ribosomal plaques: PARPs) which contain ribosomes 
attached to a superficial plaque-like structural matrix, together 
with β-actin mRNA, ZBP-1, SRP54, myosin Va and kinesin 
II molecular motor proteins. Rapid axoplasmic transport of 
microinjected heterologous radiolabeled BC1 RNA to puta-
tive PARP domains suggested that the anchored translation 
machinery potentially represents the destination of specifically 
sorted mRNAs (162). Moreover, multiple translation compo-
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nents, including ribosomal subunits and initiation factors, 
interact with the trans-membrane receptor (DCC) for netrin-1, 
suggesting that their activity can be regulated by extracellular 
signals (163). The possibility that ribosomes/mRNAs could 
be at least in part horizontally transferred into axons from 
surrounding glial cells was also discussed (142,164). In addi-
tion, it has been reported that proximal segments of transected 
sciatic nerves accumulate newly synthesized RNA in axons, 
and that these mRNAs are actually synthesized in Schwann 
cells and then transferred to neurons through a mechanism 
that requires actin cytoskeleton and myosin-Va (165).
The second problem concerns specific transport to 
dendrites and/or axons for those mRNAs that use at least 
some identical zipcodes for both localizations. Preferential 
localization depends on the entire supply of RBPs assembled 
in a given RNP, including those necessary for anchoring RNPs 
to the cytoskeleton. Several aspects of microtubule organi-
zation, among which the specific microtubule-associated 
proteins (MAPs) and motor proteins, are different between 
axons and dendrites. These differences may be at the origin 
of specific sorting of cargoes and their differential targeting in 
neurons (143,166).
4. Locally regulated stabilization and/or translation of 
pre-localized mRNAs in neurogenesis
General. Neurogenesis is an extremely complex, multi-step 
process through which self-renewing undifferentiated neural 
stem cells obtain different and integrated differentiated pheno-
types (167). This process also occurs in the adult nervous 
system following ischemic insult or damage (168,169), and has 
been implicated in learning, neuronal plasticity and memory 
formation in hippocampus (170,171).
Regulation of mRNA metabolism during development. During 
development, neurons sprout processes or growth cones, 
which explore their environment and guide pathfinding over 
extremely long distances. It is now clear that at least some 
aspects of axon guidance require axonal mRNA transla-
tion (138-140,142-147). For example, Welshhans and Bassell 
developed and used a new in vitro turning assay allowing 
these authors to demonstrate that growth cones exhibit protein 
synthesis-dependent attraction to netrin-1 and BDNF. This 
attraction is lost in neurons lacking ZBP1; concomitantly, 
BDNF-induced β-actin mRNA localization is also attenuated. 
ZBP1 is also necessary for netrin-1-induced local translation 
of β-actin mRNA (148).
Responses of growth cone to guidance cues such as netrin-1, 
BDNF, and Sema3A proceed through cycles of desensitization 
and resensitization that are critical for navigation over large 
distances. Notably, in isolated growth cones, the resensitiza-
tion step is eliminated by treatment with translation inhibitors, 
while the sensitization step is affected by inhibitors of endo-
cytosis, but not by translation inhibitors (160,172,173). Thus, 
only some steps of growth cone response to guidance cues 
require translation; when required, however, the activation of 
translation is triggered by signal transduction pathways which 
involve different kinases, including phosphatidylinositol-
3-kinase (PI3K), mammalian target of rapamycin (mTOR), 
and mitogen-activated kinases (MAPKs) (160,174).
On the other hand, in the absence of induction signals, as 
well as during the translocation to mRNA final destinations, 
translation is inhibited. Some RBPs, such as ZBP1, block 
translation initiation by inhibiting recruitment of the 60S 
subunit of the ribosome. In other cases, RBPs modulate the 
length of poly(A) tail (174,175). Conversely, the cytoplasmic 
polyadenylation element-binding protein (CPEB) binds its 
recognition element (CPE) in the 3'-UTR of its target mRNAs 
and promotes polyadenylation-induced translation (176). 
Block of CPEB function in hippocampal neurons reduces 
the translation of β-catenin, induced in the growth cones by 
neurotrophin 3 (NT3), an effect that is probably mediated by 
calcium ions and CaMKII (177).
Translational regulation by RBPs can also be influenced 
by miRNAs; these latter molecules are capable of binding 
RBPs which are, in turn, able to regulate their abun-
dance (65,174,178-180). Several miRNAs are developmentally 
regulated in mammalian neurons and have been identified in 
axons (181,182) and dendrites (65).
RBPs are expressed in region-specific patterns in 
developing brain, suggesting that they are crucial in the estab-
lishment of cell type-specific functions (174,183). For example, 
the splicing regulator Rbfox1 (A2BP1), which may involved 
in the control of neuronal excitation and seizures, in the 
mammalian brain (184), is differentially expressed at different 
developmental stages and in different brain regions (185). In 
cortical neurons, A2BP1 accumulates in the nucleus, the cell 
body and dendrites, while in cultured hippocampal neurons 
it is mainly present in the nucleus but also evidenced in the 
proximity of synapses (185).
During cell division, asymmetric segregation of RBPs 
into one daughter cell also contributes to specify its fate, and 
to generate a cell lineage. For instance, it has been recently 
demonstrated that the RNA-binding protein Stau2 is asym-
metrically distributed during progenitor divisions in the 
developing mouse cortex, thus determining the asymmetrical 
distribution of the mRNAs to which it binds (186,187). In the 
radial glial precursor, Stau2 forms a complex with other RBPs, 
such as Pumilio 2 (Pum2) and DEAD box 1 (DDX1), and 
with a number of mRNAs, including those encoding β-actin, 
mammalian prospero (prox1) (187), and the E3 ubiquitin ligase 
tripartite motif protein 32 (Trim32) (186). Perturbation of the 
complex induces premature differentiation of the radial glial 
precursors into neurons and mislocalization of the target 
mRNAs (187). Thus, it seems that asymmetric localization 
of RBPs can regulate the balance of stem cell maintenance 
versus cell differentiation, as well as cell fate.
Musashi-1 (Msi1) RBP was first reported to play a role 
in the development of the Drosophila adult external sensory 
organ (188). In mammals, Msi1 is considered a specific marker 
for neural/progenitor stem cells (189-193). It acts by suppressing 
translation of mRNAs encoding differentiation-inducing 
proteins, such as the membrane protein Numb which is involved 
in the Notch/Delta signalling cascade (118,191,194,195), and 
the cyclin-dependent kinase inhibitor p21WAF-1 (196).
The embryonic lethal abnormal vision (ELAV)-like 
proteins form a highly conserved RNA-binding protein family, 
functionally involved in the stabilization of mRNAs which 
bear AU-rich elements (ARE). As with their Drosophila homo-
logue, neuronal-specific proteins ELAV (nELAVL, originally 
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HuB, HuC, and HuD) are necessary and sufficient for inducing 
neuronal differentiation in mammalian neural precursors (197-
199) and are therefore considered markers of post-mitotic 
neurons (200). The nELAVL proteins were discovered through 
studies on paraneoplastic neurologic disorders (PND) (201). 
Some common tumors, such as small-cell lung, ovarian and 
breast cancers, produce proteins normally expressed in the 
nervous system; thus, the antitumor immune response is also 
directed against nerve cells, triggering neurologic symp-
toms (202). A number of reports have demonstrated that the 
overexpression of ELAVL proteins induces the stabilization 
of ARE-containing mRNAs. Ratti and colleagues found that 
nELAV proteins colocalize with, and bind to, Msi1 mRNA, 
in the adult mouse subventricular zone and in cultured neural 
stem/progenitor cells. They suggested that Msi1 and nELAV 
RNA-binding activities might be complementary and exert 
a different function on their target mRNAs. In other words, 
nELAV stabilization of the Msi1 transcript may prolong its 
expression during the gradual passage from proliferation to 
differentiation. This would allow the stem/progenitor cell to 
continue to divide even after Msi1 transcriptional inactiva-
tion (118). The post-transcriptional regulatory action of nELAV 
proteins on Msi1 mRNA seems to be evolutionarily restricted 
to mammals, and active from embryonic to adult neurogenesis. 
In adult neurogenic areas, nELAV activity might be transiently 
induced by spatial- and/or temporal-restricted signals. It 
has also been suggested that upregulation and cytoskeletal 
translocation of nELAV proteins, and the subsequent positive 
effects on Gap43 mRNA levels may be involved in synaptic 
plasticity and learning processes (see below), in the rat dentate 
gyrus (203,204).
As mentioned, nELAV proteins are considered early 
markers of neuronal commitment and are expressed in a 
specific temporal order in the developing nervous system of 
vertebrates. In the adult mouse, specific patterns of expres-
sion of each nELAV member have been reported in different 
neuronal types, both in the central and peripheral nervous 
systems, thus suggesting a role of nELAV proteins in the main-
tenance of various types of postmitotic neurons: for instance, 
HuC is strongly expressed in all neurons of neocortex, while 
HuD is prevalent in the large projection cells of the internal 
pyramidal layer, and HuB is detectable only in scattered 
neurons (205,206).
Of the target mRNAs regulated by the nELAV proteins 
some, in turn, encode proteins involved in mRNA metabolism, 
including mRNA which encodes the neuro-oncological ventral 
antigen 1 (Nova1) (207), a neuron-specific splicing factor that 
controls several mRNAs important for synaptic function by 
alternative maturation (208,209). Nova1 mRNA stability 
and translation are positively controlled by nELAV proteins. 
Moreover, PKC-dependent nELAV phosphorylation induces 
the recruitment of Nova1 mRNA to polysomes (207). These 
findings suggest that, as in the case of transcription factors, a 
hierarchy of RNA-binding proteins exists whose members are 
expressed as part of a regulatory cascade.
Regulation of mRNA metabolism in learning and memory. 
The most noteworthy implication of locally regulated mRNA 
translation is its possible involvement in long-term changes 
that accompany the complex processes of learning and 
memory. Although Hu proteins were originally identified as 
early markers of neuronal differentiation (210), persistence 
of HuB, HuC and HuD mRNAs in the adult nervous system, 
especially in the hippocampus and neocortex, indicates that 
they are also involved in adult neuronal plasticity and spatial 
learning (200,204,211).
In mammals, HuD can form dimers and trimers that 
associate with bound mRNAs, with cytoskeleton proteins and 
with other ELAV-like proteins to form complexes (204) which, 
in turn, may associate with polysomes to form translation-
ally competent complexes involved in learning (206) and in 
long-term memory storage and recall. The parallel increase 
of cytoskeleton proteins and HuD in the CA1 hippocampal 
region suggests a common mechanism of regulation.
A learning-specific increase of rodent nELAV proteins 
was demonstrated in both cell bodies and proximal dendrites 
of hippocampal pyramidal cells. Notably, the concomitant 
upregulation of HuD and GAP-43 expression, together with 
co-localization of HuD and GAP-43 mRNA, have been 
described in hippocampal pyramidal cells only in rodents 
that had learned two different spatial discrimination para-
digms (204,206). An effect of HuD in learning and memory 
has also been suggested by using human HuD-overexpressing 
mice, which do not show any motor/coordination deficits or 
apparent developmental abnormalities (212). Although HuD 
expression increases after learning, constitutive overexpres-
sion of this protein leads to deficits in behavioural tests such 
as contextual fear conditioning (CFC) and Morris water maze. 
These results suggest that HuD levels are tightly regulated 
and any alteration results in abnormal mRNA stabilization 
and cognitive impairment (212). Moreover, HuD is probably 
involved in the stabilization of GAP-43 in growth cones, 
where granules containing HuD also colocalize with GAP-43 
mRNA and ribosomes present in these regions (213). HuD 
was found to be associated in vivo with large cytoplasmic 
granules in the neuronal cell body and smaller granules in 
dendrites. Both types of granules were also stained with the 
ribosomal marker Y10B, suggesting that they also contain 
ribosomes (203).
The nELAV proteins seem to represent the final target of 
a cellular cascade that involves PKC, and induces the down-
stream stabilization of specific mRNAs, implicated in memory 
trace formation (206). The role of PKC was confirmed in 
cultured hippocampal neurons, where phosphorylation of HuD 
regulates BDNF, NGF, NT-3 and GAP-43 mRNAs stability 
and protein expression. HuD was suggested to be negatively 
regulated by CARM1 methyl transferase, whose activity is 
controlled by PKC-dependent phosphorylation (214).
Besides nELAV proteins, which have been the most 
extensively studied RBPs, a few other proteins are involved 
in learning and memory. Iijima and colleagues, for instance, 
identified Hematopoietic Zinc Finger (Hzf), an RBP which 
regulates the dendritic localization of mRNAs in neuronal 
cells. This protein is highly expressed in Purkinje cells and 
binds to the 3'-UTR of type 1 inositol 1,4,5-trisphosphate 
receptor (IP3R1) mRNA. Post-transcriptional regulation 
by Hzf affects synaptic plasticity and motor learning in 
cerebellum, because Hzf-/- mice exhibit severe impairments in 
motor coordination and motor learning related to cerebellar 
functions (215,216).
DI LIEGRO et al:  mRNA METABOLISM IN THE MAMMALIAN NERVOUS SYSTEM756
Obviously, the importance of RBP expression is paralleled 
by the importance of RNA cis-acting elements recognized by 
these proteins. Mutations in the 3'-UTR of mouse CamKIIα 
mRNA cause in vivo the disruption of dendritic localization 
and translation of CamKIIα, specifically affecting long-term 
memory formation, suggesting that CamKIIα may be a 
component of the translation system necessary for memory 
consolidation (217).
5. RBPs linked to human disease
Considering their critical functions in development, it is 
not surprising that altered RNA protein interactions lead to 
severe pathologies, such as neurodegenerative diseases and 
complex neurologic syndromes. Fragile X syndrome (FXS), 
the most common form of inherited mental retardation, 
depends on mutation of a gene, located in the X chromo-
some, which encodes the already mentioned RNA-binding 
protein FMRP. Most clinical cases of FXS result from 
hyper-expansion and methylation of CGG repeats within the 
promoter of fmr1 that cause deficit of its expression. FMRP 
is involved in the transport and translational regulation of 
several dendrite-localized mRNAs, including that encoding 
Arc (218,219), a protein required for hippocampal long-term 
depression (LTD) and long-term potentiation (LTP) (220), 
and the amyloid precursor protein (APP) (221,222), thus 
FMRP function is related to long-term synaptic plasticity. 
FMRP and its target mRNAs form granule-like complexes 
that are transported with a kinesin-dependent mechanism 
along microtubules (223).
Mice bearing a ko-fmr1 gene show specific defects in trace 
fear memory and LTP loss in the anterior cingulate cortex and 
lateral amygdala, while retaining normal locomotion capacity 
and pain sensitivity (224). The interaction between fmr1 and 
mGluR5, a Gp1 glutamate receptor, whose increased activity 
is one of the consequences of FMRP loss of function, was 
studied in mice bearing a ko version of fmr1, crossed with 
mice which showed a reduced mGluR5 expression. The results 
revealed that, in animals with 50% reduction of the activity 
of mGluR5, the symptoms of FXS were reduced, counter-
balancing the defects caused by fmr1 mutation (225). The 
neuronal hyperexcitability linked to a lack of FMRP, which 
generates epileptogenic responses, resembles the effects of 
a lack of the already mentioned BC1 RNA, suggesting that 
BC RNAs and FMRP have similar and overlapping modes of 
action in translational repression at synapses (226).
FMRP deficiency was reported to affect the proliferation 
rate in cultured adult neural progenitor/stem cells (aNPCs), 
isolated from ko-fmr1 mice. Moreover, mutated aNPCs have 
a higher tendency to differentiate into astrocytes as compared 
to aNPCs derived from normal brains. Notably, in mutated 
aNPCs, the Wnt signaling pathway as a whole is altered, and 
this alteration can be at the origin of the observed modification 
of cell differentiation balance (227). In vivo, deletion of FMRP 
from aNSCs leads to deficits in learning tasks that depend on 
adult hippocampal neurogenesis (228). Using ko-fmr1 mice, a 
marked impairment of cognitive functions was demonstrated, 
accompanied by a decrease of post-synaptic proteins, and 
in particular the NMDA receptor, although the relationship 
between the two events has not yet been established (229).
Alterations similar to those observed in FMRP-mutated 
mice were also found in translin knockout mice. Similar 
to FMRP, translin is an RNA-binding protein that is able 
to associate with microtubules and motor proteins, and is 
involved in the transport and translation of mRNA local-
ized in dendrites (230). Similarly, huntingtin (Htt) and 
the Htt-associated protein 1 (HAP1) have been reported to 
be part of dendritic large transport granules which also 
contain microtubule-dependent motors and transport β-actin 
mRNA (109).
Another degenerative pathology that may involve 
altered RNA-protein interactions is frontotemporal lobar 
degeneration (FTLD). FTLD has been classified into two 
subtypes: i) the first one is characterized by accumulation 
of the microtubule-associated protein τ (FTLD-τ) and ii) the 
second one is characterized by inclusion bodies that do not 
contain τ, but contain ubiquitin (FTLD-U) (231). Recently, 
a major component of FTLD-U inclusion bodies has been 
identified as TAR DNA-binding protein-43 (TDP-43), a 
protein of 43 amino acids encoded on chromosome 1, that can 
bind both DNA and RNA and functions as a splicing factor. 
Besides FTLD, amyotrophic lateral sclerosis (ALS) and 
other related neurodegenerative disorders show inclusions 
of TDP-43 and are now known as TDP-43 proteinopa-
thies (232). TDP-43 extracted from tissues of FTLD or ALS 
is often hyper phosphorylated, ubiquitinated and poorly 
soluble (231). Of note, several mutations in ALS have been 
found in the gene encoding angiogenin (ANG), a secreted 
RNase (233). Angiogenin and TDP-43 have been identified 
in stress granules, assemblies of different RBPs and mRNAs. 
Moreover, angiogenin stimulates the transcription of rRNA 
and is responsible for the production of stress-induced small 
RNAs (234). As mentioned in a previous section, TDP-43 has 
also been found in ribonucleoprotein complexes, which also 
contain Stau and FMRP (38).
As a final example, proximal spinal muscular atrophy 
(SMA) is an autosomal recessive disease caused by alteration 
of the Smn1 gene, that encodes SMN, a protein present in the 
cells as part of a complex which also contains Sm proteins and 
U snRNAs, the core components of the pre-mRNA splicing 
machinery. Recently, it has been reported that KH-type 
splicing regulatory protein (KSRP), a multifunctional protein 
closely related to chick ZBP2 and rat MARTA 1, and involved 
in the exosome-mediated degradation of ARE-containing 
mRNAs, interacts with SMN. This interaction is lost in the 
naturally occurring mutations of SMN, found in Type 1 SMA 
patients (235). Another partner of SMN is the ribonucleopro-
tein-R (hnRNPR), a protein involved in the axonal transport 
of β-actin mRNA. Loss of β-actin mRNA in axonal growth 
cones of hnRNPR-depleted motor neurons resembles the 
condition observed in SMN-deficient motor neurons (236).
6. Conclusion and future directions
As reviewed in the previous sections, a number of studies have 
previously clearly demonstrated the importance of mRNA 
localization and the regulated translation in neuronal func-
tions ranging from axon pathfinding in development to nerve 
regeneration in the adult nervous system, as well as in the 
long-lasting changes involved in learning and memory.
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However, a number of issues remain to be resolved. It is, for 
example, still uncertain whether and how mRNAs are actually 
anchored in the active sites of cell processes, e.g., whether silent 
RNPs are stably associated with specific synapses. An inter-
esting model has been proposed by Doyle and Kiebler (84), 
who suggested that RNPs containing the mRNAs necessary, 
for example, for specialized dendritic functions are not strictly 
anchored in a single site but, instead, continuously move, 
patrolling groups of synapses in dendrites. RNPs should then 
be specifically captured and modified in order to allow transla-
tion of the cargo mRNAs only from sites in which synaptic 
activity is high. They named their model ‘sushi belt model’, 
after the conveyor belt used in most Japanese sushi restaurants: 
the belt conveys sushi to all the potential consumers; however, 
the hungriest ones consume more items. In the same manner, 
synapses recently activated should be ‘hungrier’ than silent 
ones and are likely to capture/modify RNPs (84).
The most puzzling question is how a given mRNA is specifi-
cally delivered to dendrites (pathway ‘a’ in Fig. 3) or to the axon 
(pathway ‘b’ in Fig. 3). The microtubule-associated proteins 
MAP2 and τ are enriched in dendrites and axons, respectively; 
however, it remains to be determined whether these and/or 
other cytoskeleton-associated proteins have a role in selecting 
RNPs. As mRNAs already associate with some RBPs in the 
nucleus, whether RNA final destination have been decided 
from the beginning remains to be clarified, and if this occurs 
specificity factors should be found among nuclear proteins.
It seems that glial cells are involved in regulating local-
ized translation in axons, through the horizontal transfer 
of ribosomes (142). An attractive working hypothesis can 
thus be that glial cells also transfer into neurons regulatory 
factors, including transcription factors and RBPs, by sorting 
them to membrane microvesicles and/or to exosomes, which 
are then shed from glial cells and fuse with neuronal plasma 
membranes, delivering their cargoes into nerve cells.
It also remains to be defined how miRNA and RBPs coop-
erate in regulating mRNA metabolism in neurons. In these 
latter cells, ncRNAs may have an additional role in mRNA 
silencing during transport and storage processes. In conclu-
sion, mRNAs, miRNAs and RBPs form dynamic complexes 
in which part of the components probably have only structural 
functions, while others confer upon mRNA the ability to be 
specifically sorted to a given sub-cellular compartment and/or 
to be translated in response to extracellular signals. In other 
words, RNPs may be regarded as ‘mobile nucleosomes’, 
possibly originating from an ancient RNA world.
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